These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Proliferative activity in cervical intraepithelial neoplasia and cervical carcinoma. Xue Y, Feng Y, Zhu G, Zhang X. Chin Med J (Engl); 1999 Apr; 112(4):373-5. PubMed ID: 11593543 [Abstract] [Full Text] [Related]
5. The proliferative activity in dysplasia and carcinoma in situ of the uterine cervix analyzed by proliferating cell nuclear antigen immunostaining and silver-binding argyrophilic nucleolar organizer region staining. Kobayashi I, Matsuo K, Ishibashi Y, Kanda S, Sakai H. Hum Pathol; 1994 Feb; 25(2):198-202. PubMed ID: 7907076 [Abstract] [Full Text] [Related]
6. Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Barton SE, Maddox PH, Jenkins D, Edwards R, Cuzick J, Singer A. Lancet; 1988 Sep 17; 2(8612):652-4. PubMed ID: 2901519 [Abstract] [Full Text] [Related]
10. Monoclonal antibody MIB1 in the assessment of cervical squamous intraepithelial lesions. McCluggage WG, Buhidma M, Tang L, Maxwell P, Bharucha H. Int J Gynecol Pathol; 1996 Apr 17; 15(2):131-6. PubMed ID: 8786202 [Abstract] [Full Text] [Related]
11. Immunohistochemical detection of metallothionein and MIB1 in uterine cervical squamous lesions. McCluggage WG, Maxwell P, Bharucha H. Int J Gynecol Pathol; 1998 Jan 17; 17(1):29-35. PubMed ID: 9475189 [Abstract] [Full Text] [Related]
12. MIB 1 immunostaining in cervical intraepithelial neoplasia: prognostic significance in mild and moderate lesions. Garzetti GG, Ciavattini A, De Nictolis M, Lucarini G, Goteri G, Romanini C, Biagini G. Gynecol Obstet Invest; 1996 Jan 17; 42(4):261-6. PubMed ID: 8979100 [Abstract] [Full Text] [Related]
13. Immunohistochemical analysis of p53 oncoprotein and proliferating cell nuclear antigen (PCNA) in the cervix uteri. Cardillo MR, Stamp GW, Pignatelli MN, Lalani EN. Eur J Gynaecol Oncol; 1993 Jan 17; 14(6):484-90. PubMed ID: 7910135 [Abstract] [Full Text] [Related]
14. [Cervix dysplasias: study of Rb and p53 gene expression and correlation with mitotic activity]. Mathevet P, Frappart L, Hittelman W. Gynecol Obstet Fertil; 2000 Jan 17; 28(1):44-50. PubMed ID: 10774117 [Abstract] [Full Text] [Related]
15. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions. Nagai N, Oshita T, Murakami J, Ohama K. Oncol Rep; 1999 Jan 17; 6(2):325-8. PubMed ID: 10022998 [Abstract] [Full Text] [Related]
17. The evaluation of proliferative activity in CIN III and microinvasive cervical cancer and its role in recurrence. Tjalma W, Weyler J, Pollefliet C, Bogers J, Van Marck E, van Dam P, Buytaert P. Eur J Obstet Gynecol Reprod Biol; 2001 Feb 17; 94(2):270-5. PubMed ID: 11165738 [Abstract] [Full Text] [Related]
18. Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion? Brown LJ, Wells M. J Clin Pathol; 1986 Jan 17; 39(1):22-8. PubMed ID: 3950029 [Abstract] [Full Text] [Related]
19. Progressive dysregulation of proliferation during cervical carcinogenesis as measured by MPM-2 antibody staining. Hu W, Mitchell MF, Boiko IV, Linares A, Kim HG, Malpica A, Tortolero-Luna G, Hittelman WN. Cancer Epidemiol Biomarkers Prev; 1997 Sep 17; 6(9):711-8. PubMed ID: 9298579 [Abstract] [Full Text] [Related]